Because the CONCERTA tablet is nondeformable and does not appreciably alter in form from the GI tract, CONCERTA must not ordinarily be administered to patients with preexisting severe gastrointestinal narrowing (pathologic or iatrogenic, for instance: esophageal motility Conditions, compact bowel inflammatory sickness, "brief gut" syndrome resultin